×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVAX – novavax, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/1
01:50 pm
nvax
2 Growth Stocks Set to Flourishand 1 We Question [Yahoo! Finance]
Low
Report
2 Growth Stocks Set to Flourishand 1 We Question [Yahoo! Finance]
3/31
11:47 am
nvax
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook [Yahoo! Finance]
Medium
Report
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook [Yahoo! Finance]
3/30
11:03 am
nvax
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next [Yahoo! Finance]
Low
Report
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next [Yahoo! Finance]
3/30
08:13 am
nvax
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development [Yahoo! Finance]
Medium
Report
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development [Yahoo! Finance]
3/30
08:00 am
nvax
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
Medium
Report
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
3/23
06:54 am
nvax
2 Healthcare Stocks to Target This Week and 1 That Underwhelm [Yahoo! Finance]
Medium
Report
2 Healthcare Stocks to Target This Week and 1 That Underwhelm [Yahoo! Finance]
3/23
12:46 am
nvax
Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations [Yahoo! Finance]
Low
Report
Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations [Yahoo! Finance]
3/21
06:12 am
nvax
6 years since lockdown, here's a look at COVID vaccine guidance today [USA TODAY]
Low
Report
6 years since lockdown, here's a look at COVID vaccine guidance today [USA TODAY]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
4/8
06:03 am
nvax
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
Low
Report
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
3/27
11:07 am
nvax
Form SCHEDULE 13G/A NOVAVAX INC Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A NOVAVAX INC Filed by: VANGUARD GROUP INC
3/12
05:00 pm
nvax
Form 4 NOVAVAX INC For: Mar 10 Filed by: Shiver John W.
Low
Report
Form 4 NOVAVAX INC For: Mar 10 Filed by: Shiver John W.
3/9
06:14 pm
nvax
Form 4 NOVAVAX INC For: Mar 07 Filed by: Kelly James Patrick
Low
Report
Form 4 NOVAVAX INC For: Mar 07 Filed by: Kelly James Patrick
3/9
06:12 pm
nvax
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Kelly James Patrick
Low
Report
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Kelly James Patrick
3/9
06:11 pm
nvax
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Draghia-Akli Ruxandra
Low
Report
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Draghia-Akli Ruxandra
3/9
06:10 pm
nvax
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Casey Mark J
Low
Report
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Casey Mark J
3/9
06:08 pm
nvax
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Jacobs John C
Low
Report
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Jacobs John C
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/14
Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $17.00. They now have a "buy" rating on the stock.
40.5%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
TOP News Decliners
3/2
Form 8-K NOVAVAX INC For: Mar 02
-28.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: